glp 1 agonists examples The GLP-1 and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy Diabetes Patients Also Struggle to

Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

CMS GLP-1 Bridge Program: Medicare Part D coverage for weight-loss GLP-1 drugs starting July 1, 2026, including eligibility, covered medications, prior authorization, and copay rules.

Scientists were chasing an incretin hormone, and when GLP-1 was finally discovered, we found that it had a pronounced satiety effect, slowed down gastric emptying, and actually reduced postprandial insulin response